Natera, Inc. (NTRA): who owns it and who trades it
As of Nov 16, 2026, NTRA insiders reported 541 open-market sales worth $364M and no purchases in the last 12 months, with 86% of the sale value made under pre-set 10b5-1 plans. The largest seller was Matthew Rabinowitz (Chair), with $135M. 7 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Natera
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NTRA
844 funds and institutions reported NTRA shares worth $37.4B at the end of Q2 2026, about 96% of the company. The largest holder is JPMorgan Chase & Co with 9.0%.
Funds and institutions (13F) 96%Everyone else 4%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| JPMorgan Chase & Co | 12.87M | 8.98% | $3.5B | – |
| BlackRock, Inc. | 10.91M | 7.62% | $3B | +2% |
| T. Rowe Price Associates | 9.02M | 6.30% | $2.4B | -26% |
| Vanguard Capital Management LLC | 6.23M | 4.35% | $1.7B | +4% |
| Vanguard Portfolio Management LLC | 5.78M | 4.04% | $1.6B | +2% |
| FMR LLC (Fidelity) | 5.45M | 3.81% | $1.5B | +113% |
| Wellington Management Group LLP | 4.04M | 2.82% | $1.1B | -15% |
| State Street Corp | 3.66M | 2.55% | $992M | +7% |
| Duquesne Family Office LLC | 3.19M | 2.22% | $865M | +4% |
| Geode Capital Management, LLC | 2.75M | 1.92% | $745M | -1% |
| Franklin Resources Inc | 2.73M | 1.90% | $740M | +10% |
| Castle Hook Partners LP | 2.60M | 1.81% | $705M | +3% |
| Coatue Management LLC | 2.51M | 1.75% | $680M | -1% |
| AQR Capital Management LLC | 2.34M | 1.64% | $628M | +3% |
| Farallon Capital Management, L.l.c. | 2.22M | 1.55% | $602M | -31% |
| Massachusetts Financial Services Co | 1.97M | 1.38% | $535M | -3% |
| Norges Bank | 1.83M | 1.28% | $496M | – |
| Fred Alger Management, LLC | 1.78M | 1.24% | $483M | +1% |
| Goldman Sachs Group Inc | 1.72M | 1.20% | $467M | +124% |
| Sofinnova Investments, Inc. | 1.55M | 1.08% | $421M | No change |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NTRA insiders reported $0 of open-market purchases and $364M of sales. 86% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 40 | $315.26 | $12.6K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 85 | $316.93 | $26.9K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 145 | $317.87 | $46.1K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 240 | $319.77 | $76.7K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 160 | $320.02 | $51.2K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 40 | $322.00 | $12.9K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 40 | $323.06 | $12.9K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 40 | $315.28 | $12.6K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 48 | $317.33 | $15.2K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 182 | $317.96 | $57.9K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 240 | $319.22 | $76.6K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 120 | $320.07 | $38.4K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 80 | $322.88 | $25.8K | Form 4 |
| Nov 11, 2026 | Jonathan Sheena | Director | Sale plan | 40 | $324.76 | $13K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 15 | $304.57 | $4.6K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 51 | $305.75 | $15.6K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 21 | $306.46 | $6.4K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 50 | $308.20 | $15.4K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 64 | $309.08 | $19.8K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 110 | $310.17 | $34.1K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 100 | $311.31 | $31.1K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 106 | $312.20 | $33.1K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 74 | $313.32 | $23.2K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 108 | $314.71 | $34K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 169 | $315.48 | $53.3K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 1,838 | $316.87 | $582K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 56 | $318.17 | $17.8K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 105 | $319.30 | $33.5K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 131 | $320.07 | $41.9K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 51 | $321.12 | $16.4K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 16 | $321.85 | $5.1K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 40 | $323.86 | $13K | Form 4 |
| Nov 6, 2026 | Jonathan Sheena | Director | Sale plan | 45 | $325.05 | $14.6K | Form 4 |
| Nov 3, 2026 | Michael Burkes Brophy | CFO | Sale plan | 470 | $391.49 | $184K | Form 4 |
| Nov 2, 2026 | Michael Burkes Brophy | CFO | Sale plan | 8 | $388.03 | $3.1K | Form 4 |
| Nov 2, 2026 | Michael Burkes Brophy | CFO | Sale plan | 317 | $400.29 | $127K | Form 4 |
| Nov 2, 2026 | Steven Leonard Chapman | CEO | Sale plan | 21 | $387.90 | $8.1K | Form 4 |
| Nov 2, 2026 | Steven Leonard Chapman | CEO | Sale plan | 914 | $400.29 | $366K | Form 4 |
| Nov 2, 2026 | Steven Leonard Chapman | CEO | Sale plan | 2,866 | $415.64 | $1.2M | Form 4 |
| Nov 2, 2026 | John Fesko | President | Sale plan | 7 | $388.20 | $2.7K | Form 4 |
| Nov 2, 2026 | John Fesko | President | Sale plan | 295 | $400.29 | $118K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 9 | $388.20 | $3.5K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 410 | $400.29 | $164K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 200 | $405.26 | $81.1K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 432 | $406.94 | $176K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 408 | $408.08 | $166K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 520 | $409.46 | $213K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 120 | $410.71 | $49.3K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 120 | $411.73 | $49.4K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 120 | $412.88 | $49.5K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 80 | $414.16 | $33.1K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 760 | $415.52 | $316K | Form 4 |
| Nov 2, 2026 | Solomon Moshkevich | President | Sale plan | 240 | $416.45 | $99.9K | Form 4 |
| Nov 2, 2026 | Matthew Rabinowitz | Chair | Sale plan | 17 | $388.20 | $6.6K | Form 4 |
| Nov 2, 2026 | Matthew Rabinowitz | Chair | Sale plan | 731 | $400.29 | $293K | Form 4 |
| Nov 2, 2026 | Jonathan Sheena | Director | Sale plan | 3 | $388.20 | $1.2K | Form 4 |
| Nov 2, 2026 | Jonathan Sheena | Director | Sale plan | 109 | $400.29 | $43.6K | Form 4 |
| Nov 2, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFF | Sale plan | 7 | $388.20 | $2.7K | Form 4 |
| Nov 2, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFF | Sale plan | 334 | $400.29 | $134K | Form 4 |
| Oct 30, 2026 | Michael Burkes Brophy | CFO | Sale plan | 1,906 | $425.55 | $811K | Form 4 |
| Oct 28, 2026 | Michael Burkes Brophy | CFO | Sale plan | 313 | $425.32 | $133K | Form 4 |
| Oct 28, 2026 | Michael Burkes Brophy | CFO | Sale plan | 865 | $426.87 | $369K | Form 4 |
| Oct 28, 2026 | Michael Burkes Brophy | CFO | Sale plan | 1,198 | $426.34 | $511K | Form 4 |
| Oct 28, 2026 | Steven Leonard Chapman | CEO | Sale plan | 3,430 | $426.34 | $1.5M | Form 4 |
| Oct 28, 2026 | John Fesko | President | Sale plan | 898 | $426.34 | $383K | Form 4 |
| Oct 28, 2026 | Solomon Moshkevich | President | Sale plan | 1,162 | $426.34 | $495K | Form 4 |
| Oct 28, 2026 | Jonathan Sheena | Director | Sale plan | 187 | $426.34 | $79.7K | Form 4 |
| Oct 28, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFF | Sale plan | 968 | $426.34 | $413K | Form 4 |
| Oct 27, 2026 | Michael Burkes Brophy | CFO | Sale plan | 781 | $406.00 | $317K | Form 4 |
| Oct 27, 2026 | Steven Leonard Chapman | CEO | Sale plan | 2,264 | $406.00 | $919K | Form 4 |
| Oct 27, 2026 | Solomon Moshkevich | President | Sale plan | 1,010 | $406.00 | $410K | Form 4 |
| Oct 27, 2026 | Matthew Rabinowitz | Chair | Sale plan | 1,718 | $406.00 | $698K | Form 4 |
| Oct 27, 2026 | Jonathan Sheena | Director | Sale plan | 291 | $406.00 | $118K | Form 4 |
| Oct 27, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFF | Sale plan | 884 | $406.00 | $359K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 200 | $406.50 | $81.3K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 962 | $408.26 | $393K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 627 | $409.89 | $257K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 605 | $411.32 | $249K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 211 | $412.20 | $87K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 125 | $413.05 | $51.6K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 255 | $415.67 | $106K | Form 4 |
| Oct 21, 2026 | Jonathan Sheena | Director | Sale plan | 165 | $416.67 | $68.8K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 215 | $399.34 | $85.9K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 280 | $401.29 | $112K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 90 | $404.25 | $36.4K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 50 | $405.15 | $20.3K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 35 | $406.62 | $14.2K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 80 | $409.36 | $32.7K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 142 | $398.95 | $56.7K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 280 | $400.68 | $112K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 60 | $401.62 | $24.1K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 90 | $403.70 | $36.3K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 80 | $406.06 | $32.5K | Form 4 |
| Oct 16, 2026 | Jonathan Sheena | Director | Sale plan | 98 | $409.34 | $40.1K | Form 4 |
| Oct 15, 2026 | Matthew Rabinowitz | Chair | Sale plan | 286 | $388.32 | $111K | Form 4 |
| Oct 15, 2026 | Matthew Rabinowitz | Chair | Sale plan | 714 | $389.84 | $278K | Form 4 |
| Oct 15, 2026 | Matthew Rabinowitz | Chair | Sale plan | 600 | $390.21 | $234K | Form 4 |
| Oct 15, 2026 | Matthew Rabinowitz | Chair | Sale plan | 300 | $391.58 | $117K | Form 4 |
| Oct 15, 2026 | Matthew Rabinowitz | Chair | Sale plan | 800 | $393.47 | $315K | Form 4 |
| Oct 15, 2026 | Matthew Rabinowitz | Chair | Sale plan | 300 | $394.39 | $118K | Form 4 |
Latest 100 of 541 trades in the last 12 months.
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN, Director | – | $135M | Nov 2, 2026 |
| Steven Leonard Chapman | CEO AND PRESIDENT, Director | – | $61.1M | Nov 2, 2026 |
| Roelof Botha | Director | – | $34.9M | Jun 1, 2026 |
| Jonathan Sheena | Director | – | $30.4M | Nov 11, 2026 |
| Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | – | $24.9M | Nov 2, 2026 |
| Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | – | $24M | Nov 2, 2026 |
| Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | – | $22.5M | Nov 3, 2026 |
| Herm Rosenman | Director | – | $15.1M | Jun 24, 2026 |
| John Fesko | PRESIDENT, CHIEF BUS. OFFICER | – | $9.1M | Nov 2, 2026 |
| Roy D. Baynes | Director | – | $2.8M | Nov 20, 2025 |
| Gail Boxer Marcus | Director | – | $2.4M | Jun 5, 2026 |
| Rowan E Chapman | Director | – | $1.8M | Jul 15, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NTRA short interest
Low short interest. 4.2% of NTRA shares are sold short: about 1 share in 24. Over the last 12 reports the number of shares short went up 60%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 6.07M NTRA shares were sold short, 4.2% of the shares outstanding, up 3.8% from the report before. At the average daily volume of 1.46M shares, buying them all back would take about 4.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 6.07M | 4.21% | +4% | 1.46M | 4.2 |
| Oct 15, 2026 | 5.85M | 4.06% | -8% | 1.71M | 3.4 |
| Sep 30, 2026 | 6.36M | 4.41% | +32% | 1.98M | 3.2 |
| Sep 15, 2026 | 4.80M | 3.33% | -13% | 1.02M | 4.7 |
| Aug 31, 2026 | 5.51M | 3.83% | +28% | 1.26M | 4.4 |
| Aug 14, 2026 | 4.30M | 2.98% | -2% | 1.64M | 2.6 |
| Jul 31, 2026 | 4.37M | 3.03% | -12% | 931,729 | 4.7 |
| Jul 15, 2026 | 4.96M | 3.47% | -15% | 1.37M | 3.6 |
| Jun 30, 2026 | 5.82M | 4.06% | +35% | 2.12M | 2.8 |
| Jun 15, 2026 | 4.32M | 3.01% | +19% | 1.08M | 4.0 |
| May 29, 2026 | 3.61M | 2.52% | -4% | 1.62M | 2.2 |
| May 15, 2026 | 3.78M | 2.64% | -6% | 1.89M | 2.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded NTRA
Since Nov 17, 2024, 1 member of Congress reported 2 purchases and 1 sale of NTRA. The latest was a purchase by Josh Gottheimer on Sep 22, 2025, reported Oct 15, 2025.
Purchases 2Sales 1
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Sep 22, 2025 | Josh Gottheimer (D-NJ) | Purchase | $1K–$15K | Joint | Oct 15, 2025 | Report |
| Aug 22, 2025 | Josh Gottheimer (D-NJ) | Purchase | $1K–$15K | Joint | Sep 5, 2025 | Report |
| Jul 22, 2025 | Josh Gottheimer (D-NJ) | Partial sale | $1K–$15K | Joint | Aug 11, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Natera company events
Natera filed 11 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jul 6, 2026LeadershipMonica Bertagnolli notified the Board of Directors of Natera, Inc. of her intention to resign as a member of the Board and any committees of the Board, effective July 1, 2026, due to her new position with the National Academy of Medicine. Filing
- Jun 16, 2026LeadershipAmended an earlier report. The Board of Directors of Natera, Inc., a Delaware corporation (i) increased the size of the full Board from eleven to twelve members and (ii) appointed Thomas Lynch as a member of the Board, in each case effective as of June 2, 2026. Filing
- Jun 16, 2026LeadershipAs described below, on June 11, 2026, Natera, Inc. held its Annual Meeting of Stockholders. Filing
- Jun 5, 2026LeadershipThe Board of Directors of Natera, Inc., a Delaware corporation (i) increased the size of the full Board from eleven to twelve members and (ii) appointed Thomas Lynch as a member of the Board, in each case effective as of June 2, 2026. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Apr 1, 2026LeadershipThe Board of Directors of Natera, Inc., a Delaware corporation, based on the recommendation of the Board’s Nominating, Corporate Governance and Compliance Committee, (i) increased the size of the full Board from ten to eleven members and (ii) appointed Eric Rubin as a member of the Board, in each… Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Jan 12, 2026ResultsReleased financial results. Filing
- Dec 5, 2025AnnouncementThe Company issued a press release announcing its acquisition of Foresight. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Natera financials
Famous investors that hold NTRA
7 of the 50 well-known investors we track reported holding NTRA in their latest 13F filing. The largest position is Stanley Druckenmiller's, worth $1.3B.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Stanley Druckenmiller · Duquesne Family Office | Q3 2026 | 3.16M | $1.3B | 31.5% | -1% |
| Philippe Laffont · Coatue Management | Q3 2026 | 2.43M | $1B | 1.8% | -3% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 724,344 | $299M | 2.4% | -47% |
| Cathie Wood · ARK Investment Management | Q3 2026 | 546,144 | $226M | 1.3% | -21% |
| Israel Englander · Millennium Management | Q3 2026 | 131,498 | $54.3M | 0.0% | -9% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 102,369 | $42.3M | 0.2% | -39% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 26,640 | $11M | 0.0% | +334% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 6 filings named NTRA in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 4.7% |
| Nov 16, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 4.7% |
| Nov 6, 2026 | FMR LLC | 13G/A | 10.5% |
| Nov 6, 2026 | FMR LLC | 13G/A | 10.5% |
| Nov 5, 2026 | FMR LLC | 13G | 9.5% |
| Nov 5, 2026 | FMR LLC | 13G | 9.5% |
Questions about Natera, Inc. (NTRA) stock
Who owns the most NTRA stock?
The largest reported owner of Natera, Inc. (NTRA) is JPMorgan Chase & Co, with 9.0% of the company. In total, 844 funds and institutions reported holding NTRA at the end of Q2 2026, together about 96% of the shares. See the largest owners.
Are NTRA insiders buying or selling?
In the last 12 months, NTRA insiders reported no open-market purchases and 541 sales worth $364M. The latest trade was on Nov 11, 2026. See every trade.
What is the short interest in NTRA?
As of Oct 30, 2026, 6.07M NTRA shares were sold short, 4.2% of the shares outstanding, up 3.8% from the report before. At the average daily volume of 1.46M shares, buying them all back would take about 4.2 trading days (days to cover). See the history.
Have members of Congress traded NTRA?
Yes. 1 member of Congress reported 2 purchases and 1 sale of NTRA since Nov 17, 2024. The latest was reported on Oct 15, 2025. See the trades.
Which famous investors hold NTRA?
7 of the 50 well-known investors we track reported NTRA in their latest 13F filing, including Stanley Druckenmiller, Philippe Laffont, Lee Ainslie. The largest position is worth $1.3B. See all holders.
Executive pay
Natera's chief executive was paid a total of $15M for the year ended Dec 31, 2025, up 15% from $13M the year before. In the last 12 months, Natera's executives and directors bought no stock on the open market and sold $364M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.